Brought to you by:

Cell & Gene Therapy

Graphic of a drop of blood made up of small data points and nodes
Biotech

J&J lymphoma CAR-T hits 100% ORR in 10 patients

Of the 10 patients who had received one line of prior treatment, an objective response rate of 100% was recorded.
Darren Incorvaia Jun 13, 2025 1:22pm
Close-up of human eye

SpliceBio secures $135M series B for eye gene therapy trials

Jun 11, 2025 3:00am
Berger

To Gilead's new CMO, pipeline diversification is key

Jun 9, 2025 10:00am
pendulum silver metallic spheres on coloured background with drop shadow

As investors pivot from cell therapy, Immatics keeps the faith

Jun 6, 2025 3:50am
Robert F Kennedy Jr US President Donald Trumps nominee for Secretary of Health and Human Services testifies during hi

At cell and gene roundtable, officials pledge to slash regulations

Jun 5, 2025 2:50pm
An artists depiction of DNA molecules made up of tiny particles

RegenXBio links DMD gene therapy to improved outcomes

Jun 5, 2025 8:52am
More News

Cullinan's $700M pact for BCMA bispecific to pair with other TCE

Jun 5, 2025 4:38am

Ernexa's stem cell therapy shrinks ovarian tumors in mice

Jun 2, 2025 2:30pm

ASCO: Kite's CAR-T flies high in phase 1 B-cell lymphoma study

May 31, 2025 7:00pm

ASCO: Immatics cell therapy sees 56% ORR in advanced melanoma

May 31, 2025 8:00am